about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

‘It’ll be a chal­lenge’: BIO chief Crow­ley ad­dress­es seis­mic FDA over­haul

2 months ago
People
Pharma

FDA sets new date for opi­oid-fo­cused ad­vi­so­ry meet­ing af­ter ear­li­er de­lay

2 months ago
FDA+

Ex­clu­sive: Tran­scend notch­es Phase 2 win to treat PTSD, in­vig­o­rat­ing bud­ding neu­ro­plas­to­gen class

2 months ago
R&D

Lykos’ in­ter­im CEO is set to step down

2 months ago
R&D
Pharma

Blue­bird gets new M&A bid, seek­ing to top pri­vate eq­ui­ty of­fer

2 months ago
Deals
R&D

Ex­elix­is’ pri­ma­ry can­cer drug wins FDA ap­proval for neu­roen­docrine tu­mors

2 months ago
R&D
Pharma

Trump tar­iffs would in­crease costs for al­most every bio­phar­ma com­pa­ny, sur­vey claims

2 months ago
Pharma

Covid con­trar­i­an Bhat­tacharya is con­firmed as NIH chief, tak­ing over at a fraught mo­ment for fed­er­al re­search

2 months ago
People
FDA+

Trump taps act­ing CDC chief Su­san Monarez for per­ma­nent role

2 months ago
People
FDA+

Three ma­jor ques­tions on phar­ma tar­iffs Trump claims are on the way

2 months ago
Pharma
Manufacturing

BAR­DA can­cels an­nu­al bio­med­ical event for in­dus­try, gov­ern­ment reps

2 months ago
Pharma
FDA+

CDC vac­cine meet­ing, de­layed ear­li­er this year, is resched­uled

2 months ago
R&D
Pharma

Akero ex­ec calls FDA's ac­cel­er­at­ed ap­proval guid­ance for MASH drugs 'bizarre'

2 months ago
R&D
Pharma

Cal­ley Means joins White House as a spe­cial gov­ern­ment em­ploy­ee, will as­sist with MA­HA poli­cies

2 months ago
People

DOJ lawyers de­fend abor­tion pill re­stric­tions in new court fil­ing

2 months ago
FDA+
Law

As­traZeneca taps Al­teogen in deal worth more than $1.3B to make sub­cu­ta­neous can­cer drugs

2 months ago
Deals

Post-Hoc: Kennedy's an­ti-vac­cine ac­tions should­n't sur­prise any­one

2 months ago
Pharma
FDA+

Boston Phar­ma, build­ing off MASH mo­men­tum, mulls an IPO ahead of Phase 3 tri­al

2 months ago
R&D

Up­dat­ed: White House pulls Wel­don's nom­i­na­tion to lead CDC at last minute

2 months ago
Pharma
FDA+

Mallinck­rodt and En­do ex­plor­ing a $7B merg­er — re­port

2 months ago
Deals

No­vo Nordisk will join le­gal row over FDA's re­moval of semaglu­tide from short­age list

2 months ago
Law

Pli­ant calls it quits on Phase 2b id­io­path­ic pul­monary fi­bro­sis study

2 months ago
R&D

Ex­clu­sive: In­fec­tious dis­ease doc­tors con­sid­er 'mi­ni-ACIP' if RFK erodes CDC vac­cine pan­el

3 months ago
FDA+

HHS’ vac­cine in­jury pan­el in lim­bo af­ter month­long meet­ing de­lay

3 months ago
FDA+
First page Previous page 123456 Next page Last page
A service from the Financial Times